跳到正文
原文
Nature 健康护理主题·· 5 天前AI 评分45

Triglyceride-glucose glycemic variability index在危重不稳定心绞痛患者中的预后价值:机器学习联合独立医院验证

Prognostic value of triglyceride-glucose glycemic variability index in critically ill unstable angina patients via machine learning with independent hospital validation

AI 导读

对1,444例来自MIMIC-IV 3.1数据库的危重不稳定心绞痛成人患者的回顾性分析显示,较高TyG-GVI水平与ICU死亡率升高相关(HR 2.29,95% CI 1.43–3.66,n=108;ICU病死率7.5%),也与院内死亡率(n=190;住院病死率13.2%)相关,但后者未在所有模型设定中均达统计学显著。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

The triglyceride-glucose (TyG) index is associated with outcomes in critical illness, but the prognostic value of combining it with glycemic variability, the TyG-glycemic variability index (TyG-GVI), has not been evaluated in critically ill patients with unstable angina. In this study we examined the association between TyG-GVI and ICU and in-hospital mortality and developed an interpretable machine-learning model for mortality risk. We retrospectively analyzed 1,444 adult patients with unstable angina from the MIMIC-IV 3.1 database (2008–2022) as the development cohort, dichotomized at the median TyG‑GVI. Associations with ICU and in-hospital mortality were estimated using Cox proportional-hazards and logistic regression, and the dose-response relationship was modelled with restricted cubic splines. Random Forest, XGBoost and LightGBM classifiers were developed with Boruta confirmatory importance analysis and SHAP-based interpretation, and the optimal model was externally validated in an independent retrospective cohort of 340 ICU patients with unstable angina from the Quzhou Affiliated Hospital of Wenzhou Medical University. A total of 108 ICU deaths (7.5%) and 190 in-hospital deaths (13.2%) occurred. Compared with the low TyG-GVI group, high TyG-GVI was associated with ICU mortality in the fully adjusted Cox model (HR 2.29, 95% CI 1.43–3.66) and with in-hospital mortality (HR 1.54, 95% CI 1.11–2.15), although the latter did not reach statistical significance in every model specification. The dose-response relationship was non-linear (P for non-linearity  < 0.01 for ICU mortality and < 0.05 for in-hospital mortality), with a data-derived nadir at a TyG-GVI of approximately 3.135. Random Forest achieved the numerically highest discrimination in the development cohort (AUC 0.830) and in the external validation cohort (AUC 0.874). High TyG-GVI was independently associated with ICU mortality and was also associated with in-hospital mortality in critically ill patients with unstable angina. An interpretable machine-learning model incorporating TyG-GVI showed consistent discrimination performance in the development and external validation cohorts and has been deployed as a web-based research prototype. Prospective validation and formal assessment of calibration and clinical utility are required before clinical use.

Abbreviations

AUC:

Area under the receiver operating characteristic curve

BIDMC:

Beth Israel Deaconess Medical Center

CI:

Confidence interval

CV:

Coefficient of variation

DCA:

Decision curve analysis

GVI:

Glycemic variability index

ICU:

Intensive care unit

MIMIC-IV:

Medical Information Mart for Intensive Care IV

ML:

Machine learning

NPV:

Negative predictive value

OASIS:

Oxford Acute Severity of Illness Score

PPV:

Positive predictive value

RCS:

Restricted cubic spline

RF:

Random Forest

SAPS II:

Simplified Acute Physiology Score II

SHAP:

SHapley Additive exPlanations

TyG:

Triglyceride-glucose

UA:

Unstable angina

Acknowledgements

The authors wish to acknowledge no additional contributions for this manuscript.

Funding

This project was funded by National Nature Science Foundation of China (No: 82505254); Technology Project of Zhejiang Provincial Health Commission (No: 2025KY1779); Quzhou Municipal Science and Technology Bureau (No: 2023K117).

Author information

Author notes

  1. Zhiguang Zheng, Junwei Qiu and Yunru Qian contributed equally to this work.

Authors and Affiliations

  1. The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, China

    Zhiguang Zheng, Yanqiu Jiang & Ke-Jie He

  2. School of Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China

    Junwei Qiu & Yunru Qian

  3. Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China

    Shengshan Xu

Authors

  1. Zhiguang Zheng
  2. Junwei Qiu
  3. Yunru Qian
  4. Shengshan Xu
  5. Yanqiu Jiang
  6. Ke-Jie He

Corresponding author

Correspondence to Ke-Jie He.

Ethics declarations

Consent for publication

Not applicable.

Ethics approval and consent to participate

The MIMIC-IV database was approved by the institutional review boards of the Massachusetts Institute of Technology and the Beth Israel Deaconess Medical Center, with a waiver of informed consent owing to de-identification. The external cohort was approved by the Institutional Review Board of the Quzhou Affiliated Hospital of Wenzhou Medical University (approval No. 2026-074), which waived the requirement for written informed consent. All methods were performed in accordance with the Declaration of Helsinki and relevant institutional regulations. This retrospective study utilized anonymized public epidemiological data derived from the MIMIC database as well as de-identified retrospective patient data from our hospital. All patient information was anonymized to protect individual privacy, with no identifiable personal data included. Given the retrospective design and fully anonymized nature of the data, ethical approval and written informed consent from patients were exempted by our institutional ethics committee. Thus, formal ethical approval and individual informed consent were not required for this study.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, Z., Qiu, J., Qian, Y. et al. Prognostic value of triglyceride-glucose glycemic variability index in critically ill unstable angina patients via machine learning with independent hospital validation. Sci Rep (2026). https://doi.org/10.1038/s41598-026-79521-y

Download citation

  • Received: 04 September 2026

  • Accepted: 31 October 2026

  • Published: 15 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-79521-y

Keywords

来源:Nature 健康护理主题 · nature.com